Osteopenia Recruiting Phase 2 Trials for Pamidronic acid (DB00282)

Also known as: Osteopaenia / Bone loss

IndicationStatusPhase
DBCOND0015922 (Osteopenia)Recruiting2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT02074631Prevention of Bone Loss After Pediatric Hematopoietic Cell TransplantationPrevention